查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2048102

生物製藥物流市場－全球產業規模、佔有率、趨勢、機會、預測：按服務、營運類型、地區和競爭格局分類，2021-2031年

Bio-Pharma Logistics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Type of Operation By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球生物製藥物流市場專注於藥品和生物製藥的溫控儲存和運輸，預計將從 2025 年的 828.9 億美元成長到 2031 年的 1,258.7 億美元，複合年成長率為 7.21%。

這項擴張的驅動力來自全球對溫度敏感生物製藥（例如疫苗和基因療法）日益成長的需求，這些製劑需要精確的環境控制；以及製藥生產的全球化程度不斷提高，這需要強大的跨境分銷網路。預計到2024年，美國藥品批發商的銷售額將達到8,620億美元，年增10.4%，凸顯了該產業的龐大規模。然而，如何遵守分散的國際法規結構和不同的合規標準仍然是一個重大挑戰，這導致了延誤和效率低下。

市場概覽
預測期 2027-2031
市場規模：2025年 828.9億美元
市場規模：2031年 1258.7億美元
複合年成長率：2026-2031年 7.21%
成長最快的細分市場 低溫運輸
最大的市場 北美洲

市場促進因素

市場的主要驅動力是生物製藥和生物相似藥產業的快速擴張，這需要先進的低溫運輸基礎設施來運輸高以金額為準、對溫度敏感的貨物。這要求物流供應商擴展其針對複雜治療藥物的專業運輸能力，IAG Cargo 的「恆溫運輸」產品在 2024 年的貨運量同比成長 22%，以及全球航空貨運需求成長 11.3%，都印證了這一點。同時，採用物聯網和人工智慧技術來提高供應鏈的可視性和最佳化效率變得至關重要，這使得企業能夠部署先進的感測器和預測分析技術來監控產品品質、減少浪費並確保合規性。根據 Tive 發布的《2025 年視覺化現況》報告，目前已有 60% 的公司在使用基於物聯網的追蹤系統。

市場挑戰

全球生物製藥物流市場成長的主要限制因素是國際法規結構的碎片化。由於缺乏統一的溫度控制、包裝和搬運合規標準，物流業者面臨許多挑戰，導致驗證流程複雜、營運瓶頸以及海關延誤難以預測，進而威脅時效性強的藥品運輸。全球航空貨運需求不斷成長，2024年6月成長了14.1%，進一步加劇了這個問題。監管障礙阻礙了生物製藥的有效分銷，導致倉儲、合規和處置成本增加，從而限制了整體市場潛力。

市場趨勢

兩大關鍵市場趨勢正在湧現：一是轉向永續和可重複使用的低溫運輸包裝解決方案，二是用於細胞和基因治療的超低溫低溫運輸基礎設施的擴展。為了最大限度地減少對環境的影響，相關人員正從一次性聚苯乙烯轉向耐用、可重複使用的材料；例如，冷鏈技術公司（Cold Chain Technologies）預計，到2024年底，透過引入可重複使用的保溫運輸容器，將減少超過1億英鎊的廢棄物掩埋量。同時，個人化醫療的商業化需要-196 度C的極低溫儲存，這推動了對高度專業化的超低溫冷鏈能力的需求。 Cryoport公司預計2024年營收將成長20%，這主要得益於對商業化細胞和基因療法的支持，也印證了這一點。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球生物製藥物流市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依服務類型（運輸、倉儲/配送、附加價值服務）
    • 依業務類型（低溫運輸、非低溫運輸）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美生物製藥物流市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲生物製藥物流市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區生物製藥物流市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲生物製藥物流市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲生物製藥物流市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球生物製藥物流市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Kerry Logistics Network Limited
  • Deutsche Post AG
  • DHL Group
  • Kuehne+Nagel International AG
  • UPS（Marken）Inc.
  • DB Schenker
  • FedEx Corp
  • Nippon Express Co Ltd
  • World Courier Inc
  • SF Express

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20292

The Global Bio-Pharma Logistics Market, which specializes in the temperature-controlled storage and transportation of pharmaceutical and biological products, is projected to grow from USD 82.89 Billion in 2025 to USD 125.87 Billion by 2031, at a 7.21% CAGR. This expansion is driven by escalating global demand for temperature-sensitive biologics like vaccines and gene therapies, requiring precise environmental controls, and the increasing globalization of pharmaceutical manufacturing, which necessitates robust cross-border distribution networks. U.S. pharmaceutical distributors$862 billion in sales in 2024, up 10.4%, highlight the sectors volume, yet a primary challenge remains the complexity of navigating fragmented international regulatory frameworks with divergent compliance standards causing delays and inefficiencies.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 82.89 Billion
Market Size 2031USD 125.87 Billion
CAGR 2026-20317.21%
Fastest Growing SegmentCold Chain
Largest MarketNorth America

Market Driver

A key market driver is the rapid expansion of the biologics and biosimilars sector, demanding sophisticated cold chain infrastructure for high-value, temperature-sensitive payloads. This requires logistics providers to expand specialized capacity for complex therapies, as evidenced by a 22% year-over-year increase in tonnage for IAG Cargo's Constant Climate product in 2024, alongside an 11.3% rise in global air cargo demand. Concurrently, the pivotal adoption of IoT and AI for real-time supply chain visibility and optimization allows operators to deploy advanced sensors and predictive analytics, monitoring product integrity, reducing spoilage, and ensuring regulatory compliance, with 60% of companies now using IoT-powered tracking according to Tive's 'State of Visibility 2025' report.

Market Challenge

The primary impediment to the Global Bio-Pharma Logistics Markets growth is fragmented international regulatory frameworks. Logistics providers face inconsistent compliance standards for temperature monitoring, packaging, and handling across different jurisdictions, leading to complex validation processes, operational bottlenecks, and unpredictable customs delays that threaten time-sensitive medical shipments. This issue is amplified by rising global air cargo demand, which increased by 14.1% in June 2024, as regulatory hurdles obstruct efficient bio-pharma distribution, thereby increasing costs for storage, compliance, and spoilage, and restricting overall market potential.

Market Trends

Two significant market trends are emerging: the transition to sustainable and reusable cold chain packaging solutions, and the expansion of ultra-cold chain infrastructure for cell and gene therapies. Stakeholders are moving from single-use polystyrene to durable, multi-trip materials to minimize environmental impact, with Cold Chain Technologies, for instance, avoiding over 100 million pounds of landfill waste by late 2024 through reusable thermal shipping. Simultaneously, the growing commercialization of personalized medicines, requiring cryogenic storage at temperatures as low as -1960C, is driving demand for highly specialized ultra-cold chain capabilities, as shown by Cryoport's 20% revenue increase in 2024 from supporting commercial cell and gene therapies.

Key Market Players

  • Kerry Logistics Network Limited
  • Deutsche Post AG
  • DHL Group
  • Kuehne + Nagel International AG
  • UPS (Marken) Inc.
  • DB Schenker
  • FedEx Corp
  • Nippon Express Co Ltd
  • World Courier Inc
  • SF Express

Report Scope

In this report, the Global Bio-Pharma Logistics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bio-Pharma Logistics Market, By Service

  • Transportation
  • Warehousing and Distribution
  • Value Added Services

Bio-Pharma Logistics Market, By Type of Operation

  • Cold Chain
  • Non-cold Chain

Bio-Pharma Logistics Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bio-Pharma Logistics Market.

Available Customizations:

Global Bio-Pharma Logistics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bio-Pharma Logistics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service (Transportation, Warehousing and Distribution, Value Added Services)
    • 5.2.2. By Type of Operation (Cold Chain, Non-cold Chain)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Bio-Pharma Logistics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service
    • 6.2.2. By Type of Operation
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Bio-Pharma Logistics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service
        • 6.3.1.2.2. By Type of Operation
    • 6.3.2. Canada Bio-Pharma Logistics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service
        • 6.3.2.2.2. By Type of Operation
    • 6.3.3. Mexico Bio-Pharma Logistics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service
        • 6.3.3.2.2. By Type of Operation

7. Europe Bio-Pharma Logistics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service
    • 7.2.2. By Type of Operation
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Bio-Pharma Logistics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service
        • 7.3.1.2.2. By Type of Operation
    • 7.3.2. France Bio-Pharma Logistics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service
        • 7.3.2.2.2. By Type of Operation
    • 7.3.3. United Kingdom Bio-Pharma Logistics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service
        • 7.3.3.2.2. By Type of Operation
    • 7.3.4. Italy Bio-Pharma Logistics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Service
        • 7.3.4.2.2. By Type of Operation
    • 7.3.5. Spain Bio-Pharma Logistics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Service
        • 7.3.5.2.2. By Type of Operation

8. Asia Pacific Bio-Pharma Logistics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service
    • 8.2.2. By Type of Operation
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Bio-Pharma Logistics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service
        • 8.3.1.2.2. By Type of Operation
    • 8.3.2. India Bio-Pharma Logistics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service
        • 8.3.2.2.2. By Type of Operation
    • 8.3.3. Japan Bio-Pharma Logistics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service
        • 8.3.3.2.2. By Type of Operation
    • 8.3.4. South Korea Bio-Pharma Logistics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service
        • 8.3.4.2.2. By Type of Operation
    • 8.3.5. Australia Bio-Pharma Logistics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service
        • 8.3.5.2.2. By Type of Operation

9. Middle East & Africa Bio-Pharma Logistics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service
    • 9.2.2. By Type of Operation
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Bio-Pharma Logistics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service
        • 9.3.1.2.2. By Type of Operation
    • 9.3.2. UAE Bio-Pharma Logistics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service
        • 9.3.2.2.2. By Type of Operation
    • 9.3.3. South Africa Bio-Pharma Logistics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service
        • 9.3.3.2.2. By Type of Operation

10. South America Bio-Pharma Logistics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service
    • 10.2.2. By Type of Operation
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Bio-Pharma Logistics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service
        • 10.3.1.2.2. By Type of Operation
    • 10.3.2. Colombia Bio-Pharma Logistics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service
        • 10.3.2.2.2. By Type of Operation
    • 10.3.3. Argentina Bio-Pharma Logistics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service
        • 10.3.3.2.2. By Type of Operation

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Bio-Pharma Logistics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Kerry Logistics Network Limited
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Deutsche Post AG
  • 15.3. DHL Group
  • 15.4. Kuehne + Nagel International AG
  • 15.5. UPS (Marken) Inc.
  • 15.6. DB Schenker
  • 15.7. FedEx Corp
  • 15.8. Nippon Express Co Ltd
  • 15.9. World Courier Inc
  • 15.10. SF Express

16. Strategic Recommendations

17. About Us & Disclaimer